Today BMM announced that it will invest 6.5 million Euros in 4 programs led by talented young investigators. QTIS/e participates in the DialysisXS program, which is led by  Joris Rotmans from Leiden University Medical Center. This program aims to improve vascular access for dialysis patients using tissue engineered vascular grafts. DialysisXS receives 1.3 million Euros from the BMM program.

The official BMM press release can be found here.

<< Back